Keywords
ST-segment elevation myocardial infarction
multivessel disease
non-infarct related artery
percutaneous coronary intervention
multivessel disease
non-infarct related artery
percutaneous coronary intervention
How to Cite
Mora Ayestarán, N., Zubia Olaskoaga, F., & Roy Añón, I. (2020). Non-culprit lesion revascularization in ST-segment elevation myocardial infarction with multivessel disease. Osagaiz: Osasun-Zientzien Aldizkaria, 4(1). https://doi.org/10.26876/osagaiz.1.2020.292
Abstract
Percutaneous coronary intervention (PCI) of the culprit lesion is now considered the gold standard in the treatment for patients with ST-segment elevation myocardial infarction (STEMI). Multivessel coronary artery disease (MVD) is found in approximately 40-65% of patients with STEMI undergoing primary PCI. The optimal reperfusion strategy and timing of revascularization (MV-PCI, S-PCI or IRA-PCI) in hemodynamically stable patients with STEMI and multivessel disease remains uncertain. Recent studies suggest that complete revascularization is superior to culprit-only revascularization in this context. In this review, we summarize the available evidence on treatment options for patients with STEMI and MVD.